HomeCompareKDFI vs JNJ

KDFI vs JNJ: Dividend Comparison 2026

KDFI yields 9.57% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KDFI wins by $17.7K in total portfolio value
10 years
KDFI
KDFI
● Live price
9.57%
Share price
$20.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$1,748.24
Full KDFI calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — KDFI vs JNJ

📍 KDFI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKDFIJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KDFI + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KDFI pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KDFI
Annual income on $10K today (after 15% tax)
$813.59/yr
After 10yr DRIP, annual income (after tax)
$1,486.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, KDFI beats the other by $782.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KDFI + JNJ for your $10,000?

KDFI: 50%JNJ: 50%
100% JNJ50/50100% KDFI
Portfolio after 10yr
$28.9K
Annual income
$1,288.01/yr
Blended yield
4.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KDFI
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KDFI buys
0
JNJ buys
0
No recent congressional trades found for KDFI or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKDFIJNJ
Forward yield9.57%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$37.7K$20.0K
Annual income after 10y$1,748.24$827.78
Total dividends collected$13.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KDFI vs JNJ ($10,000, DRIP)

YearKDFI PortfolioKDFI Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,657$957.17$10,676$355.77+$981.00KDFI
2$13,516$1,042.79$11,407$389.39+$2.1KKDFI
3$15,592$1,129.97$12,198$426.53+$3.4KKDFI
4$17,902$1,218.26$13,056$467.62+$4.8KKDFI
5$20,462$1,307.22$13,987$513.12+$6.5KKDFI
6$23,291$1,396.43$14,998$563.56+$8.3KKDFI
7$26,407$1,485.49$16,098$619.52+$10.3KKDFI
8$29,829$1,574.04$17,295$681.69+$12.5KKDFI
9$33,579$1,661.73$18,599$750.82+$15.0KKDFI
10$37,678$1,748.24$20,022$827.78+$17.7KKDFI

KDFI vs JNJ: Complete Analysis 2026

KDFIStock

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the FTSE US High-Yield Treasury Rotation Index. Under normal circumstances, the fund will invest at least 80% of its total assets in components of the index. As of each monthly reconstitution, the underlying index will be fully exposed to one of the three following sub-indexes: FTSE US Treasury 1-5 Years Index; FTSE US Treasury 7-10 Years Index; and FTSE US High-Yield Market BB/B-Rated Capped Custom Index. It is non-diversified.

Full KDFI Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this KDFI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KDFI vs SCHDKDFI vs JEPIKDFI vs OKDFI vs KOKDFI vs MAINKDFI vs ABBVKDFI vs MRKKDFI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.